B. Demissei

发表

Novel endotypes in heart failure: effects on guideline-directed medical therapy

P. Ponikowski, A. Zwinderman, N. Samani, 2018, European heart journal.

BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors

K. Musunuru, S. Domchek, B. Ky, 2022, Frontiers in Cardiovascular Medicine.

Early cardiac effects of contemporary radiation therapy in breast cancer patients.

B. Ky, J. Plastaras, H. Shou, 2020, International journal of radiation oncology, biology, physics.

Bio‐adrenomedullin as a marker of congestion in patients with new‐onset and worsening heart failure

N. Samani, K. Dickstein, J. Cleland, 2019, European journal of heart failure.

Optimizing clinical risk stratification in acute heart failure

B. Demissei, 2017 .

Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma.

C. Simone, S. Feigenberg, A. Maity, 2019, International journal of radiation oncology, biology, physics.

Left ventricular segmental strain and the prediction of cancer therapy-related cardiac dysfunction.

C. Davatzikos, Yong Fan, M. Scherrer-Crosbie, 2020, European heart journal cardiovascular Imaging.

Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.

Evanette K. Burrows, Edward M. Krause, Mark J. Ramos, 2022, The Lancet. Haematology.

Plasma biomarkers to predict or rule out early post‐discharge events after hospitalization for acute heart failure

P. Ponikowski, C. O'connor, M. Metra, 2017, European journal of heart failure.

Plasma biomarkers to predict or rule out early post-discharge events in patients discharged after an acute heart failure hospital admission

P. Ponikowski, C. O'connor, D. J. Veldhuisen, 2017 .

Demissei, B. G. et al. (2017) Plasma biomarkers to predict or rule out early post- discharge events in patients discharged after an acute heart failure hospital

C. O'connor, D. J. Veldhuisen, M. Metra, 2017 .

Physical activity during and after breast cancer therapy and associations of baseline physical activity with changes in cardiac function by echocardiography

R. Hubbard, K. Schmitz, Justin C. Brown, 2020, Cancer medicine.

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction

R. Hubbard, A. DeMichele, K. Fox, 2019, Journal of the American Heart Association.

Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients.

P. Ponikowski, C. O'connor, J. Cleland, 2016, International journal of cardiology.

Risk stratification in acute heart failure: reply

A. Voors, B. Demissei, Biniyam G. Demissei, 2018, European journal of heart failure.

Bearing allostatic load: insights into a more equitable future within cardio-oncology.

V. Narayan, B. Demissei, M. Barrett, 2022, Trends in molecular medicine.

Optimizing clinical use of biomarkers in high‐risk acute heart failure patients

P. Ponikowski, C. O'connor, M. Metra, 2016, European journal of heart failure.

Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab

A. DeMichele, A. Clark, V. Narayan, 2021, JACC. Basic to translational science.

Longitudinal Right Ventricular Systolic Function Changes in Breast Cancer Patients Treated With Cardiotoxic Cancer Therapy

R. Hubbard, P. Thavendiranathan, Jade C. S. Chung, 2022, JACC. CardioOncology.

A multimarker multi‐time point‐based risk stratification strategy in acute heart failure: results from the RELAX‐AHF trial

P. Ponikowski, G. Filippatos, G. Felker, 2017, European journal of heart failure.

Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review.

V. Narayan, B. Ky, J. Januzzi, 2020, Journal of the American College of Cardiology.

Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.

P. Ponikowski, A. Zwinderman, N. Samani, 2018, Journal of the American College of Cardiology.

Coronary angiography in worsening heart failure: determinants, findings and prognostic implications

P. Ponikowski, A. Zwinderman, N. Samani, 2017, Heart.

Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial.

P. Ponikowski, C. O'connor, M. Metra, 2016, International journal of cardiology.

A systematic review of epidemiology, treatment and prognosis of heart failure in adults in Ethiopia

B. Demissei, Tenaadam A Tsega, 2018, Journal of cardiovascular medicine.

Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.

P. Ponikowski, C. O'connor, J. Cleland, 2018, International journal of cardiology.

Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapy

R. Hubbard, A. DeMichele, S. Domchek, 2019, Cancer.

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.

D. Kent, G. Sledge, B. Ky, 2019, Clinical breast cancer.

A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure

P. Ponikowski, M. Metra, J. Cleland, 2017, European journal of heart failure.

Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial

P. Ponikowski, G. Filippatos, G. Felker, 2019, ESC heart failure.

OP-EHEA180728 4269..4276

K. Dickstein, P. Harst, J. Cleland, 2018 .

Should non-cardiovascular mortality be considered in the SCORE model? Findings from the Prevention of Renal and Vascular End-stage Disease (PREVEND) cohort

P. Harst, H. Hillege, D. Postmus, 2014, European Journal of Epidemiology.

Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab

R. Hubbard, A. Clark, V. Narayan, 2020, JACC. CardioOncology.

Early Changes in Physical Activity and Quality of Life with Thoracic Radiation Therapy in Breast Cancer, Lung Cancer, and Lymphoma.

K. Cengel, S. Feigenberg, A. Berman, 2020, International journal of radiation oncology, biology, physics.

Trajectories of renal biomarkers and new‐onset heart failure in the general population: Findings from the PREVEND study

Lyanne M. Kieneker, H. Hillege, S. Bakker, 2023, European Journal of Heart Failure.

Cardiovascular Function Phenotypes in Response to Cardiotoxic Breast Cancer Therapy.

R. Hubbard, S. Domchek, V. Narayan, 2019, Journal of the American College of Cardiology.

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction

R. Hubbard, A. DeMichele, K. Fox, 2020, Journal of the American Heart Association.

Bio‐adrenomedullin as a marker of congestion in patients with new‐onset and worsening heart failure

N. Samani, K. Dickstein, J. Cleland, 2019, European journal of heart failure.

Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapy

T. Alonzo, R. Gerbing, W. Border, 2023, Frontiers in Cardiovascular Medicine.